Article

Bleomycin Electrosclerotherapy (BEST) of Slow-Flow Vascular Malformations (SFVMs) in Children

Published: 2025-09-01Reading: 1 min

Abstract

Bleomycin electrosclerotherapy (BEST) is a promising treatment for slow-flow vascular malformations (SFVMs). Due to limited paediatric data, this study aimed to assess the safety, effectiveness, and patient-reported outcomes of BEST in children with SFVMs.

Keywords

Vascular Malformations Bleomycin Electrosclerotherapy Pediatric Interventional Radiology Sclerotherapy Slow-flow Malformations Venous Malformations Lymphatic Malformations

Hashtags

#VascularMalformations #PediatricRadiology #InterventionalRadiology #Sclerotherapy

This article is published on an external journal. Click below to read the full text.

Read full article ↗

How to cite: GlobalCastMD. Bleomycin Electrosclerotherapy (BEST) of Slow-Flow Vascular Malformations (SFVMs) in Children. GlobalCastMD Medical Library. 2025-09-01. https://origin-library.globalcastmd.com/article/10972

Abstract

Keywords

Hashtags

Comments (0)